Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3388-3391

  Labrou, Maria ^a   Michail, George ^a   Ntokou, Eleni ^a   Pittaras, Theodore E ^b   Pournaras, Spyros ^a   Tsakris, Athanassios ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOXACILLIN; OXACILLIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; ASSAY; BACTERIAL GENE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; EVALUATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; OXACILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THIGH INFECTION; TREATMENT RESPONSE;

ANIMALS; ANTI-BACTERIAL AGENTS; DICLOXACILLIN; FEMALE; MICE; MICE, INBRED BALB C; OXACILLIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THIGH; VANCOMYCIN;

EID: 84861154762     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00103-12     Document Type: Article

References (21)

1. Andes D, van Ogtrop ML, Peng J, Craig WA. 2002. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob. Agents Chemother. 46:3484-3489. (Pubitemid 35192915)
2. Chen FJ, Hiramatsu K, Huang IW, Wang CH, Lauderdale TL. 2009. Panton-Valentine leukocidin (PVL)-positive methicillin-susceptible and resistant Staphylococcus aureus in Taiwan: identification of oxacillin-susceptible mecA-positive methicillin-resistant S. aureus. Diagn. Microbiol. Infect. Dis. 65:351-357.
3. Chini S, et al. 2008. Clonal evolution and antibiotic resistance profile of methicillin-resistant Staphylococcus aureus in Greece during a five-year period, abstr C2-231, p 156. Abstr. 48th Annu. Intersci. Conference Antimicrob. Agents Chemother. (ICAAC). American Society for Microbiology, Washington, DC.
4. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 8th ed. Approved standard M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multi-locus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015. (Pubitemid 30140551)
6. Giannouli S, et al. 2010. Detection of mutations in the FemXAB protein family in oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates. J. Antimicrob. Chemother. 65:626-633.
7. Hegde SS, Reyes N, Skinner R, Difuntorum S. 2008. Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus. J. Antimicrob. Chemother. 61:169-172.
8. Hososaka Y, et al. 2007. Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J. Infect. Chemother. 13:79-86. (Pubitemid 46669295)
9. Ikonomidis A, et al. 2008. Investigation of oxacillin efficacy among oxacillin-susceptible, mecA positive, Staphylococcus aureus clinical isolates by population analyses, bactericidal assays and experimental thigh infections. Antimicrob. Agents Chemother. 52:3905-3908.
10. Jo DS, Montgomery CP, Yin S, Boyle-Vavra S, Daum RS. 2011. Improved oxacillin treatment outcomes in experimental skin and lung infection by methicillin-resistant Staphylococcus aureus containing a vraSR operon deletion. Antimicrob. Agents Chemother. 55:2818-2823.
11. Joukhadar C, Pillai S, Wennersten C, Moellering RC, Jr, Eliopoulos GM. 2010. Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 54:773-777.
12. LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ. 2008. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim- sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrob. Agents Chemother. 52:2156-2162. (Pubitemid 351758553)
13. Levine DP, Fromm BS, Reddy BR. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
14. Lina G, et al. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132. (Pubitemid 30265628)
15. Pournaras S, et al. 2011. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Int. J. Antimicrob. Agents 37:244-247.
16. Rohrer S, Maki H, Berger-Bachi B. 2003. What makes resistance to methicillin heterogeneous? J. Med. Microbiol. 52:605-607. (Pubitemid 36981465)
17. Saeed K, Dryden M, Parnaby R. 2010. Oxacillin-susceptible MRSA, the emerging MRSA clone in the UK? J. Hosp. Infect. 76:267-268.
18. Sakiniene E, Collins LV. 2002. Combined antibiotic and free radical trap treatment is effective at combating Staphylococcus aureus-induced septic arthritis. Arthritis Res. 4:196-200. (Pubitemid 34460759)
19. Sakoulas G, et al. 2001. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J. Clin. Microbiol. 39:3946-3951. (Pubitemid 33029765)
20. Small PM, Chambers HF. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231. (Pubitemid 20177385)
21. van Belkum A, et al. 1998. Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study. J. Clin. Microbiol. 36:1653-1659.